UK Markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
634.00+6.01 (+0.96%)
At close: 4:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3706.95
52-week low 3447.82
50-day moving average 3636.64
200-day moving average 3598.92

Share statistics

Avg vol (3-month) 3382.1k
Avg vol (10-day) 3318.77k
Shares outstanding 585.28M
Implied shares outstanding 6N/A
Float 883.93M
% held by insiders 10.94%
% held by institutions 186.49%
Shares short (14 Nov 2021) 4699.61k
Short ratio (14 Nov 2021) 42.21
Short % of float (14 Nov 2021) 40.93%
Short % of shares outstanding (14 Nov 2021) 40.83%
Shares short (prior month 14 Oct 2021) 4735.38k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 24.14%
Operating margin (ttm)29.28%

Management effectiveness

Return on assets (ttm)25.88%
Return on equity (ttm)126.53%

Income statement

Revenue (ttm)3.14B
Revenue per share (ttm)36.73
Quarterly revenue growth (yoy)12.30%
Gross profit (ttm)1.57B
EBITDA 1.02B
Net income avi to common (ttm)756.86M
Diluted EPS (ttm)7.77
Quarterly earnings growth (yoy)19.80%

Balance sheet

Total cash (mrq)145.2M
Total cash per share (mrq)1.71
Total debt (mrq)963.19M
Total debt/equity (mrq)127.50
Current ratio (mrq)1.48
Book value per share (mrq)8.23

Cash flow statement

Operating cash flow (ttm)764.52M
Levered free cash flow (ttm)568.77M